AstraZeneca Buys 20% Stake in Cambridge Antibody
88847
AstraZeneca Plc, the UK&#39;s second biggest drugmaker, bought a 19.9 percent stake in Cambridge Antibody Technology Group Plc, an unprofitable biotechnology company, for 75 million pounds ($139 million).
218831
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise $13.3 billion deal to buy   Europe's biggest biotech firm Serono SEO.VX on Thursday,   creating a new force in European pharmaceuticals.
696796
The US cleaning products maker has agreed to buy back a 29 percent stake from Germany&#39;s Henkel KGaA (HNKG_p.DE: Quote, Profile, Research) .
194227
The Qatar Investment Authority said Thursday it had acquired a 20 percent stake in the London Stock Exchange, the same day that Borse Dubai announced a deal to acquire the Nasdaq Stock Market's 28 percent stake in the LSE.
640611
Cambridge cancer drug maker Ariad Pharmaceuticals Inc. signed a major deal with Merck &amp; Co. Inc. yesterday in which the global pharmaceutical giant will pay $75 million to collaborate on developing and selling Ariad's experimental drug to treat sarcomas, a type of tumor that attacks fat, muscle, and bone.
197311
In a deal valued at $20 million, Check Point Software Technologies gels a new growth strategy: buy others.
677195
Eats Zantaz Inc Cambridge-based software firm Autonomy is buying US document storage and retrieval company Zantaz Inc.â¦
385319
GlaxoSmithKline PLC said Friday it had acquired the privately held biotechnology company Domantis Ltd. for 230 million pounds ($454 million) in cash.
738544
The cancer diagnostic equipment maker is expected to announce that it will acquire Spring Bioscience, a developer of antibodies, for $28.9 million in cash.
506286
BOSTON (CBS.MW) - Pharmaceutical powerhouse Pfizer is buying a 5 percent stake in biotechnology researcher Medarex under their newly signed collaboration deal, according to Medarex Chief Executive Donald Drakeman.
641166
Abbott Laboratories Inc. has agreed to buy the nutrition firm EAS Inc. for $320 million. The two companies said Monday the cash transaction is expected to close in the fourth quarter, pending regulatory approval.
513568
One Equity Partners agreed to sell its stake in Quintiles Transnational, a big manager of clinical drug trials, to its C.E.O. and two buyout firms.
725667
The Nasdaq Stock Market is selling a nearly 20 percent stake to Borse Dubai and is taking control of the Nordic exchange operator OMX as part of a sweeping settlement of their battle for control of OMX.
57452
Shares in Anglo-Swedish drug giant AstraZeneca drop more than 8% in value after the failure of its Iressa drug in a major clinical trial.
189959
German drug firm Schwarz Pharma is being bought in a 4.4bn euros deal, the third industry tie-up in recent days.
640929
Shares of Cambridge-based Genzyme were up slightly today on news that the drug maker won approval for a drug to treat childhood leukemia.
477715
Pharmaceutical group GlaxoSmithKline (GSK) has agreed to buy antibody therapy developer Domantis for 230 million pounds.